Ligand validation:4EXZ

RET: RETINAL

RET is a Ligand Of Interest in 4EXZ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4EXZ_RET_B_202	27%	30%	0.117	0.899	0.6	2.13	-	2	0	0	24%	1
4EXZ_RET_A_202	13%	30%	0.246	0.789	0.71	2.05	-	7	18	0	100%	0.8
7LHO_RET_A_202	84%	73%	0.084	0.946	0.65	0.4	1	-	6	0	100%	1
4GKC_RET_A_201	68%	38%	0.102	0.914	1.06	1.37	-	6	2	0	100%	1
5F6B_RET_B_201	61%	43%	0.112	0.901	0.74	1.46	-	3	3	0	100%	1
4QYP_RET_B_201	60%	33%	0.117	0.901	1.07	1.56	1	5	12	0	100%	1
4EEJ_RET_B_201	57%	25%	0.134	0.91	1.07	1.97	1	5	6	0	100%	1
4OV0_RET_A_301	100%	8%	0.027	0.992	0.76	3.77	-	15	8	0	100%	1
9F9J_RET_A_317	100%	71%	0.026	0.991	0.7	0.44	1	-	5	0	100%	1
3UTY_RET_A_301	100%	5%	0.028	0.992	2.48	2.7	6	12	2	0	100%	1
3UTX_RET_B_301	100%	6%	0.042	0.988	2.42	2.7	5	12	4	0	100%	1
7XJE_RET_A_301	99%	6%	0.048	0.983	1.99	2.98	4	14	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.